Transplant Medicine
Prophylactic drugs avert de novo infections from HBcAb-positive liver grafts
Published in Blood Weekly, February 17th, 2005
According to recent research from South Korea, "hepatitis B virus (HBV) prophylaxis is necessary to prevent de novo hepatitis B infection from hepatitis B core antibody (HBcAb)-positive donors. However, which protocol is more effective is somewhat controversial. Also, it is uncertain whether it is necessary to administer HBV prophylaxis for hepatitis B surface antibody (HBsAb)-positive recipients."
"This study attempted to determine whether it is necessary to administer HBV prophylaxis for HBsAb-positive patients and to evaluate the efficacy of an hepatitis B immune...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-02-17)
More Articles from Blood Weekly
- Biomedical Engineering
Sintered polymeric microsphere matrix used for tissue-engineered bone formation - Embryonic Stem Cell Research
Embryos derived from PSOS SCs exhibit enhanced preimplantation development - Embryonic Stem Cell Research
Endothelial cells within embryonic muscles are source of myogenic progenitors - Hematology
Heme-degrading capacity of RES does not surpass ability to eliminate bilirubin - Neurogenesis
CNS SCs differentiate into functional neuronal circuits in 3-D collagen gels - Acute Lymphoblastic Leukemia
Intensive chemotherapy and imatinib rapidly induces CR in BCR-ABL+ AML patients - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
